These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 18559695)

  • 1. Alternative splicing of 3-hydroxy-3-methylglutaryl coenzyme A reductase is associated with plasma low-density lipoprotein cholesterol response to simvastatin.
    Medina MW; Gao F; Ruan W; Rotter JI; Krauss RM
    Circulation; 2008 Jul; 118(4):355-62. PubMed ID: 18559695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of HMGCR alternative splicing in statin efficacy.
    Medina MW; Krauss RM
    Trends Cardiovasc Med; 2009 Jul; 19(5):173-7. PubMed ID: 20005478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HNRNPA1 regulates HMGCR alternative splicing and modulates cellular cholesterol metabolism.
    Yu CY; Theusch E; Lo K; Mangravite LM; Naidoo D; Kutilova M; Medina MW
    Hum Mol Genet; 2014 Jan; 23(2):319-32. PubMed ID: 24001602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in the 3-hydroxyl-3-methylglutaryl coenzyme a reductase gene is associated with racial differences in low-density lipoprotein cholesterol response to simvastatin treatment.
    Krauss RM; Mangravite LM; Smith JD; Medina MW; Wang D; Guo X; Rieder MJ; Simon JA; Hulley SB; Waters D; Saad M; Williams PT; Taylor KD; Yang H; Nickerson DA; Rotter JI
    Circulation; 2008 Mar; 117(12):1537-44. PubMed ID: 18332269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common SNPs in HMGCR in micronesians and whites associated with LDL-cholesterol levels affect alternative splicing of exon13.
    Burkhardt R; Kenny EE; Lowe JK; Birkeland A; Josowitz R; Noel M; Salit J; Maller JB; Pe'er I; Daly MJ; Altshuler D; Stoffel M; Friedman JM; Breslow JL
    Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):2078-84. PubMed ID: 18802019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of rs3846662 and HMGCR alternative splicing in statin efficacy and baseline lipid levels in familial hypercholesterolemia.
    Leduc V; Bourque L; Poirier J; Dufour R
    Pharmacogenet Genomics; 2016 Jan; 26(1):1-11. PubMed ID: 26466344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined influence of LDLR and HMGCR sequence variation on lipid-lowering response to simvastatin.
    Mangravite LM; Medina MW; Cui J; Pressman S; Smith JD; Rieder MJ; Guo X; Nickerson DA; Rotter JI; Krauss RM
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1485-92. PubMed ID: 20413733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein signatures of cholesteryl ester transfer protein and HMG-CoA reductase inhibition.
    Kettunen J; Holmes MV; Allara E; Anufrieva O; Ohukainen P; Oliver-Williams C; Wang Q; Tillin T; Hughes AD; Kähönen M; Lehtimäki T; Viikari J; Raitakari OT; Salomaa V; Järvelin MR; Perola M; Davey Smith G; Chaturvedi N; Danesh J; Di Angelantonio E; Butterworth AS; Ala-Korpela M
    PLoS Biol; 2019 Dec; 17(12):e3000572. PubMed ID: 31860674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
    Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
    Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of the functional variant in the 3-hydroxy-3-methylglutaryl-coenzyme a reductase gene with low-density lipoprotein-cholesterol in Japanese.
    Hiura Y; Tabara Y; Kokubo Y; Okamura T; Goto Y; Nonogi H; Miki T; Tomoike H; Iwai N
    Circ J; 2010 Mar; 74(3):518-22. PubMed ID: 20145341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of
    Liu Z; Zhou Y; Jin M; Liu S; Liu S; Yang K; Li H; Luo S; Jureti S; Wei M; Fu Z
    PeerJ; 2024; 12():e18144. PubMed ID: 39351366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming statin resistance in prostate cancer cells by targeting the 3-hydroxy-3-methylglutaryl-CoA-reductase.
    Göbel A; Pählig S; Motz A; Breining D; Traikov S; Hofbauer LC; Rachner TD
    Biochem Biophys Res Commun; 2024 May; 710():149841. PubMed ID: 38588613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between HMGCR genetic variation, alternative splicing, and statin efficacy.
    Medina MW
    Discov Med; 2010 Jun; 9(49):495-9. PubMed ID: 20587337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variation in 3-hydroxy-3-methylglutaryl CoA reductase modifies the chemopreventive activity of statins for colorectal cancer.
    Lipkin SM; Chao EC; Moreno V; Rozek LS; Rennert H; Pinchev M; Dizon D; Rennert G; Kopelovich L; Gruber SB
    Cancer Prev Res (Phila); 2010 May; 3(5):597-603. PubMed ID: 20403997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RP1-13D10.2 Is a Novel Modulator of Statin-Induced Changes in Cholesterol.
    Mitchel K; Theusch E; Cubitt C; Dosé AC; Stevens K; Naidoo D; Medina MW
    Circ Cardiovasc Genet; 2016 Jun; 9(3):223-30. PubMed ID: 27071970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of plasma low density lipoprotein cholesterol by select 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in mice devoid of low density lipoprotein receptors.
    Bisgaier CL; Essenburg AD; Auerbach BJ; Pape ME; Sekerke CS; Gee A; Wölle S; Newton RS
    J Lipid Res; 1997 Dec; 38(12):2502-15. PubMed ID: 9458274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) splice variant with an alternative exon 1 potentially encoding an extended N-terminus.
    Stormo C; Kringen MK; Grimholt RM; Berg JP; Piehler AP
    BMC Mol Biol; 2012 Sep; 13():29. PubMed ID: 22989091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RHOA is a modulator of the cholesterol-lowering effects of statin.
    Medina MW; Theusch E; Naidoo D; Bauzon F; Stevens K; Mangravite LM; Kuang YL; Krauss RM
    PLoS Genet; 2012; 8(11):e1003058. PubMed ID: 23166513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol potentiates effect of simvastatin on inhibition of mevalonate pathway in human endometrial stromal cells.
    Villanueva JA; Sokalska A; Cress AB; Ortega I; Bruner-Tran KL; Osteen KG; Duleba AJ
    J Clin Endocrinol Metab; 2013 Mar; 98(3):E455-62. PubMed ID: 23386644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common variants of HMGCR, CETP, APOAI, ABCB1, CYP3A4, and CYP7A1 genes as predictors of lipid-lowering response to atorvastatin therapy.
    Poduri A; Khullar M; Bahl A; Sehrawat BS; Sharma Y; Talwar KK
    DNA Cell Biol; 2010 Oct; 29(10):629-37. PubMed ID: 20578904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.